BioVoice News September 2016 Issue 5 Volume 1 | Page 17

As per Dr M C Mishra , Director , All India Institute of Medical Sciences ( AIIMS ), “ India is already taking major steps though one by one . National Cancer Institute is the biggest medical science project in the history of India . We are introducing Gama Knife Robotic Surgery and targeted therapy through nano-biotechnology approach which is in offing .”
Dr N K Ganguly , former Director General , ICMR recently feels that India must learn from other countries like Africa where there is lot of clinical research happening in the country . “ Perhaps India too could accelerate its activities as a learning . Anti-leishmanial and anti-TB fight in India . Nano particle based anti-cancer drugs , 3rd generation biosimilars can be all affordable ones if we try hard here in our country ,” he says .
Skilled human resources must be core of any action plan
Dr Jitendra Singh suggests setting up of ICMR units in private-sector medical colleges and institutions . “ A mutually rewarding mechanism could be worked out wherein , while the private institutions having ICMR or other registered research body units could be rewarded with

“ certain incentives , on the other hand ICMR would have the advantage of tapping and grooming young medicos with research aptitude ,” he added while speaking at an event in Delhi recently .

In order to improve health services , the government on the other hand says that it has identified 187 districts in the
India must learn from other countries like Africa where there is lot of clinical research happening in the country . “ Perhaps India too could accelerate its activities as a learning . Anti-leishmanial and anti-TB fight in India . Nano particle based anti-cancer drugs , 3rd generation biosimilars can be all affordable ones if we try hard here in our country .
Dr N K Ganguly , former Director General , Indian Council for Medical Research
BIOVOICENEWS . COM 17